Single nucleotide polymorphisms of the melanocortin-3 receptor gene are associated with substrate oxidation and first-phase insulin secretion in offspring of type 2 diabetic subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 3, 2007, Pages 1112-1117

  Rutanen, Jarno ^a   Pihlajamäki, Jussi ^a   Vänttinen, Markku ^a   Salmenniemi, Urpu ^a   Ruotsalainen, Eija ^a   Kuulasmaa, Teemu ^a   Kainulainen, Sakari ^a   Laakso, Markku ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOCORTIN 3 RECEPTOR;

ADULT; ALLELE; ARTICLE; BODY MASS; CALORIMETRY; DEMOGRAPHY; ENERGY METABOLISM; GENETIC SCREENING; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPID OXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33947533651     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1201     Document Type: Article

References (23)

1. Chhajlani V 1996 Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem Mol Biol Int 38:73-80
2. Murphy KG, Bloom SR 2005 Peripheral influences on central melanocortin neurons. Peptides 26:1744-1752
3. Cone RD 2005 Anatomy and regulation of the central melanocortin system. Nat Neurosci 8:571-578
4. Ste Marie L, Miura GI, Marsh DJ, Yagaloff K, Palmiter RD 2000 A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA 97:12339-12344
5. Rutanen J, Pihlajamäki J, Karhapää P, Vauhkonen I, Kuusisto J, Moilanen Mykkänen L, Laakso M 2004 The Val103Ile polymorphism of melanocortin-4 receptor regulates energy expenditure and weight gain. Obes Res 12:1060-1066
6. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F 1997 Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141
7. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P 2000 Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106:253-262
8. Lee YS, Poh LK, Loke KY 2002 A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J Clin Endocrinol Metab 87:1423-1426
9. Feng N, Young SF, Aguilera G, Puricelli E, Adler-Wailes DC, Sebring NG, Yanovski JA 2005 Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes 54:2663-2667
10. Hani EH, Dupont S, Durand E, Dina C, Gallina S, Gantz I, Froguel P 2001 Naturally occurring mutations in the melanocortin receptor 3 gene are not associated with type 2 diabetes mellitus in French Caucasians. J Clin Endocrinol Metab 86:2895-2898
11. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M, Cone RD 2000 A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141:3518-3521
12. Salmenniemi U, Ruotsalainen E, Pihlajamäki J, Vauhkonen I, Kainulainen S, Punnonen K, Vanninen E, Laakso M 2004 Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 110:3842-3848
13. Alberti KG, Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
14. 2001 Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497
15. The International HapMap Consortium 2003 The International HapMap Project. Nature 426:789-796
16. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D 2005 Efficiency and power in genetic association studies. Nat Genet 37:1217-1223
17. R Development Core Team 2006 R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing
18. Barrett JC, Fry B, Maller J, Daly MJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
19. Hoggard N, Johnstone AM, Faber P, Gibney ER, Elia M, Lobley G, Rayner V, Horgan G, Hunter L, Bashir S, Stubbs RJ 2004 Plasma concentrations of α-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation. Clin Endocrinol (Oxf) 61:31-39
20. Yiannakouris N, Melistas L, Kontogianni M, Heist K, Mantzoros CS 2004 The Val81 missense mutation of the melanocortin 3 receptor gene, but not the 1908c/T nucleotide polymorphism in lamin A/C gene, is associated with hyperleptinemia and hyperinsulinemia in obese Greek Caucasians. J Endocrinol Invest 27:714-720
21. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte Jr D 1992 Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 13:387-414
22. Benoit SC, Air EL, Coolen LM, Strauss R, Jackman A, Clegg DJ, Seeley RJ, Woods SC 2002 The catabolic action of insulin in the brain is mediated by melanocortins. J Neurosci 22:9048-9052
23. Kreier F, Kap YS, Mettenleiter TC, van Heijningen C, van der Vliet J, Kalsbeek A, Sauerwein HP, Fliers E, Romijn JA, Buijs RM 2006 Tracing from fat tissue, liver, and pancreas: a neuroanatomical framework for the role of the brain in type 2 diabetes. Endocrinology 147:1140-1147